These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 16475813

  • 1. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
    Denisov AY, Chen G, Sprules T, Moldoveanu T, Beauparlant P, Gehring K.
    Biochemistry; 2006 Feb 21; 45(7):2250-6. PubMed ID: 16475813
    [Abstract] [Full Text] [Related]

  • 2. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM, Sborgi L, de Alba E.
    J Mol Recognit; 2012 Dec 21; 25(12):665-73. PubMed ID: 23192964
    [Abstract] [Full Text] [Related]

  • 3. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
    García-Sáez AJ, Mingarro I, Pérez-Payá E, Salgado J.
    Biochemistry; 2004 Aug 31; 43(34):10930-43. PubMed ID: 15323553
    [Abstract] [Full Text] [Related]

  • 4. Unique structural features of a BCL-2 family protein CED-9 and biophysical characterization of CED-9/EGL-1 interactions.
    Woo JS, Jung JS, Ha NC, Shin J, Kim KH, Lee W, Oh BH.
    Cell Death Differ; 2003 Dec 31; 10(12):1310-9. PubMed ID: 12894216
    [Abstract] [Full Text] [Related]

  • 5. Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells.
    McKenzie MD, Carrington EM, Kaufmann T, Strasser A, Huang DC, Kay TW, Allison J, Thomas HE.
    Diabetes; 2008 May 31; 57(5):1284-92. PubMed ID: 18252892
    [Abstract] [Full Text] [Related]

  • 6. Bid: a Bax-like BH3 protein.
    Billen LP, Shamas-Din A, Andrews DW.
    Oncogene; 2008 Dec 31; 27 Suppl 1():S93-104. PubMed ID: 19641510
    [Abstract] [Full Text] [Related]

  • 7. Heat-induced dimerization of BCL-xL through alpha-helix swapping.
    Denisov AY, Sprules T, Fraser J, Kozlov G, Gehring K.
    Biochemistry; 2007 Jan 23; 46(3):734-40. PubMed ID: 17223694
    [Abstract] [Full Text] [Related]

  • 8. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H, Lee GI, Sedey KA, Kutzki O, Park HS, Orner BP, Ernst JT, Wang HG, Sebti SM, Hamilton AD.
    J Am Chem Soc; 2005 Jul 27; 127(29):10191-6. PubMed ID: 16028929
    [Abstract] [Full Text] [Related]

  • 9. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD, Fairlie WD, Hadley EB, Lee HS, Umezawa N, Nikolovska-Coleska Z, Wang S, Huang DC, Tomita Y, Gellman SH.
    J Am Chem Soc; 2007 Jan 10; 129(1):139-54. PubMed ID: 17199293
    [Abstract] [Full Text] [Related]

  • 10. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
    Feng Y, Zhang L, Hu T, Shen X, Ding J, Chen K, Jiang H, Liu D.
    Arch Biochem Biophys; 2009 Apr 01; 484(1):46-54. PubMed ID: 19161970
    [Abstract] [Full Text] [Related]

  • 11. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
    Zhang YH, Bhunia A, Wan KF, Lee MC, Chan SL, Yu VC, Mok YK.
    J Mol Biol; 2006 Dec 01; 364(3):536-49. PubMed ID: 17011577
    [Abstract] [Full Text] [Related]

  • 12. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S, Choi M, Baek K, Yoon HS.
    Proteins; 2015 Jul 01; 83(7):1262-72. PubMed ID: 25907960
    [Abstract] [Full Text] [Related]

  • 13. Structural plasticity underpins promiscuous binding of the prosurvival protein A1.
    Smits C, Czabotar PE, Hinds MG, Day CL.
    Structure; 2008 May 01; 16(5):818-29. PubMed ID: 18462686
    [Abstract] [Full Text] [Related]

  • 14. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Lee DH, Ha JH, Kim Y, Bae KH, Park JY, Choi WS, Yoon HS, Park SG, Park BC, Yi GS, Chi SW.
    Biochem Biophys Res Commun; 2011 May 20; 408(4):541-7. PubMed ID: 21527247
    [Abstract] [Full Text] [Related]

  • 15. BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma.
    Goldsmith KC, Liu X, Dam V, Morgan BT, Shabbout M, Cnaan A, Letai A, Korsmeyer SJ, Hogarty MD.
    Oncogene; 2006 Aug 03; 25(33):4525-33. PubMed ID: 16568093
    [Abstract] [Full Text] [Related]

  • 16. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
    Day CL, Smits C, Fan FC, Lee EF, Fairlie WD, Hinds MG.
    J Mol Biol; 2008 Jul 25; 380(5):958-71. PubMed ID: 18589438
    [Abstract] [Full Text] [Related]

  • 17. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
    Yin H, Lee GI, Sedey KA, Rodriguez JM, Wang HG, Sebti SM, Hamilton AD.
    J Am Chem Soc; 2005 Apr 20; 127(15):5463-8. PubMed ID: 15826183
    [Abstract] [Full Text] [Related]

  • 18. Photocontrollable peptide-based switches target the anti-apoptotic protein Bcl-xL.
    Kneissl S, Loveridge EJ, Williams C, Crump MP, Allemann RK.
    Chembiochem; 2008 Dec 15; 9(18):3046-54. PubMed ID: 19012295
    [Abstract] [Full Text] [Related]

  • 19. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death.
    Yin XM.
    Gene; 2006 Mar 15; 369():7-19. PubMed ID: 16446060
    [Abstract] [Full Text] [Related]

  • 20. Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity.
    Wilson-Annan J, O'Reilly LA, Crawford SA, Hausmann G, Beaumont JG, Parma LP, Chen L, Lackmann M, Lithgow T, Hinds MG, Day CL, Adams JM, Huang DC.
    J Cell Biol; 2003 Sep 01; 162(5):877-87. PubMed ID: 12952938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.